Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02448043 · ClinicalTrials.gov registry record · NA
Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure
A NA study of Intraocular Pressure and Nail Growth Cessation, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT02448043 is a NA study of Intraocular Pressure and Nail Growth Cessation that has completed, run by Northwestern University. The registered enrollment target is 45 participants, below the 83-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02448043, a NA study of Intraocular Pressure and Nail Growth Cessation, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Topical prostaglandin agents are used to help reduce eye pressure in glaucoma patients. Bimatoprost (Lumigan 0.01%) is such an agent (Allergan, Inc.). Several of our patients on bimatoprost and an observational study of patients on bimatoprost in another center reported that fingernails grew longer and became less brittle using the topical eye drops to the eyes. The purpose of the double-blinded study is to determine whether the application of the eye drops directly to the proximal nail fold of one hand using the opposite hand as a control will result in longer nails, less brittle nails, and reduced eye pressures should any of the medication be absorbed into the systemic circulation.
Conditions Studied
Interventions
- DRUG Bimatoprost 0.01%
- OTHER Placebo: saline
Study Locations (1)
Illinois
- David J. Palmer, MD - Glenview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-06-04 |
| Est. Completion | 2016-05-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02448043
The ClinicalTrials.gov registry entry for NCT02448043 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (46% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Intraocular Pressure appearing as the primary indexed condition, and to 2 interventions - of which Bimatoprost 0.01% is the first listed.
NCT02448043 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02448043 about?
NCT02448043 is a clinical study titled "Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure". Topical prostaglandin agents are used to help reduce eye pressure in glaucoma patients. Bimatoprost (Lumigan 0.01%) is such an agent (Allergan, Inc.). Several of our patients on bimatoprost and an observational study of patients on bimatoprost in another center reported that fingernails grew longer ...
What is the current status of trial NCT02448043?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2015-06-04. Estimated completion is 2016-05-06.
What conditions does trial NCT02448043 study?
This clinical trial studies the following conditions: Intraocular Pressure, Nail Growth Cessation.
What interventions are being tested in trial NCT02448043?
The interventions under investigation include: Bimatoprost 0.01% (DRUG), Placebo: saline (OTHER).
Who is sponsoring clinical trial NCT02448043?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02448043 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraocular Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Raised End-Tidal pCo2 on Choroidal Volume
RECRUITING · NA
-
IOP Elevation Study
RECRUITING · NA
-
Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings
COMPLETED · NA
-
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
RECRUITING · Phase 4
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
-
Anterior Segment Optical Coherence Tomography Microstent Positioning
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.